Obama to Turn Up Pressure for Deal on Budget Cuts


Doug Mills/The New York Times


President Obama spoke at a White House auditorium surrounded by emergency responders.







WASHINGTON — President Obama, back from his three-day golf getaway, on Monday made use of his bully pulpit, while Congress remains out all week, to turn up the pressure for a bipartisan agreement to avoid indiscriminate across-the-board budget cuts that will otherwise hit March 1.




Speaking in a White House auditorium surrounded by blue-uniformed emergency responders to illustrate some of the jobs threatened if the cuts were to take effect, Mr. Obama warned that military readiness and vital domestic services would be hurt “if Congress allows this meat-cleaver approach to take place.”


“Changes like this affect our responsibility to respond to threats in unstable parts of the world,” the president said. “These cuts are not smart, they are not fair, they will hurt our economy, they will add hundreds of thousands of Americans to the unemployment rolls. This is not an abstraction — people will lose their jobs.”


Some Republicans in Congress have proposed alternative savings that would spare any cuts in military spending but not in domestic accounts. Mr. Obama and Congressional Democrats are calling for a mix of spending cuts and additional tax revenues by closing some tax breaks for wealthy investors and corporations.


Mr. Obama’s comments were among his harshest toward Republicans, and reflected the political frame that he has devised to try to force Republicans into compromising with him by supporting some higher revenues — something they so far refuse to do.


“The ideas that the Republicans have proposed ask nothing of the wealthiest Americans or biggest corporations, so the burden is all on first responders or seniors or middle-class families,” Mr. Obama said, adding that those proposals would “slash Medicare and investments that create good middle-class jobs.”


“So now Republicans in Congress face a simple choice,” he added. “Are they willing to compromise to protect vital investments in education and health care and national security and all the jobs that depend on them, or would they rather put hundreds of thousands of jobs and our entire economy at risk just to protect a few special-interest tax loopholes that benefit only the wealthiest Americans and biggest corporations?”


Republicans, seeking to put blame on Mr. Obama if the cuts occur, have repeatedly noted that the White House proposed the sequester idea during debt talks in mid-2011. But both parties overwhelmingly supported the proposal as part of their deal. And as Mr. Obama said on Tuesday, the purpose of the sequester was to threaten something so unthinkable that the two parties would come together to agree on an alternative.


The president’s latest deficit reduction push comes as the heads of his 2010 deficit reduction commission — former Senator Alan K. Simpson and Erskine B. Bowles, a former chief of staff to President Bill Clinton — unveil a new plan that would reduce the deficit by $2.4 trillion through a series of spending cuts and an overhaul of the tax system.


When Congress returns from a winter recess next week, just days remain before the deadline for the so-called sequester of spending cuts, a deadline that already was moved once — at the start of the year — to allow more time for the two parties to negotiate.


Read More..

Drug Makers Increasingly Join Fight Against Doping



Now, a growing number of pharmaceutical companies are trying to prevent their drugs from the same fate by joining with antidoping officials to develop tests to detect the illegal use of their drugs among athletes.


Two major drug makers, Roche and GlaxoSmithKline, have begun evaluating every new drug candidate for its potential to be abused by athletes and have agreed to share information about those products with the World Anti-Doping Agency, known as WADA, which polices drug use in international sports. Several other smaller companies have provided proprietary information about specific drugs. A conference in Paris in November dedicated to the topic drew 250 participants.


The development reflects a significant shift from the days when drug makers paid little attention to how their products could be abused by athletes, said David Howman, the director general of the antidoping agency. In the past, drug makers “felt that any publicity in relation to antidoping control would be negative,” he said. “But what they discovered is the opposite happened.”


Instead of shying away from such stories, Roche and Glaxo have promoted their involvement as an example of good corporate citizenship. Last year, Glaxo went so far as to sponsor the testing laboratories for the London Games, the first time in Olympic history that an antidoping laboratory had a named corporate sponsor.


Pauline Williams, who leads the team at Glaxo that runs the antidoping initiative, said the cooperation with WADA grew out of that sponsorship. “What the London 2012 involvement led to was a real pride and willingness, and a positive attitude toward this continued engagement,” she said. Since the start of the program, the company said it has shared information about four of its projects, and development of a test for one drug is under way.


Antidoping officials have long sought information from drug companies. For instance, Amgen, which developed EPO, helped develop a test for Aranesp, another of its drugs that has been used in doping, in advance of the 2002 Salt Lake Olympics. But such arrangements were ad hoc and fairly simple, said Olivier Rabin, the antidoping agency’s science director. “It was almost more by chance when it was happening,” he said.


Relationships between antidoping officials and pharmaceutical companies have sometimes been tense. In 2006, Amgen was criticized for sponsoring the Tour of California at a time when EPO abuse was rampant among cyclists. Although the company said it had sponsored the race to raise awareness about doping, it was later revealed that the organizers had failed to test for EPO, short for erythropoietin, a synthetic hormone that, like Aranesp, stimulates the production of red blood cells.


“They were associated with some things in the past which we felt were probably inappropriate,” Mr. Howman said. “What we had to do was start the conversation from scratch, and say let’s see how we can work together.”


Steven Elliott, the Amgen scientist who invented Aranesp, said the misperceptions went both ways. He said some believed, wrongly, that biotechnology companies were developing drugs that could be misused by athletes as a way to increase sales. “There was this uneasiness about that,” said Mr. Elliott, who recently retired but continues to work as a liaison between biotechnology companies and the antidoping agency. “There had to be this realization that it was a win-win for both sides.”


Antidoping officials began to work more closely with drug makers after 2004, when Dr. Rabin heard that athletes were talking about a new version of EPO, called CERA, that was being developed by Roche, and asked the company for help.


“We were shocked when they first contacted us,” recalled Barbara Leishman, who oversees the antidoping program there. She said company scientists had not realized that athletes were following the drug’s development so closely. “This is not the sort of thing we like to hear about our compounds.”


Roche then worked with the antidoping agency to develop a blood test for the new drug, turning over proprietary compounds, called reagents, that would help officials test for their drug. Because of the complex nature of the drug, which mimics the body’s own hormones, and the development of the test, the project took years.


In 2009, blood samples from six athletes taken during the Beijing Olympics tested positive for CERA. Other drug makers took note of the media attention Roche received for the collaboration, Mr. Howman said. “Once there’s a foot in the water, then you can follow and walk right in,” he said.


Roche broadened its agreement with WADA, expanding the project to screen all of its drugs in development. Glaxo followed suit and around the same time, two major industry groups representing biotechnology and pharmaceutical companies adopted policies encouraging their members to cooperate.


Halting the abuse of new prescription drugs is only part of the antidoping picture. Athletes today are believed to use a variety of methods to gain an advantage, from transfusing their own blood to taking tiny quantities of tried-and-true doping agents. And some performance-enhancing drugs gain life in illicit laboratories, as was the case with “the clear,” the designer steroid developed in the Bay Area Laboratory Co-operative that toppled star athletes like Marion Jones.


Still, pharmaceutical companies have an important role to play given how complex new drugs have become, and how athletes are increasingly using substances that closely mimic the body’s natural processes, officials said.


“Developing detection methods to show that the substance taken in a synthetic form is different than your natural substance is more challenging,” said Matthew Fedoruk, the science director for the United States Anti-Doping Agency.


Many pharmaceutical companies already have the tools to create a doping test for their products because the Food and Drug Administration and other regulatory bodies require them to show how the drug passes through the body. During the development process, the companies design reagents to help identify the drug. Amgen and other companies, like the biotechnology company Affymax — which makes a competing anemia drug called Omontys — have given WADA some of these reagents for use in developing tests.


Still, Dr. Rabin and others said some companies needed persuading and did not return his calls. In those cases, he said, he uses peer pressure, reminding them that other companies are also participating.


“We know the progress of their drugs, and we know that at some point collaboration will naturally come,” he said. “We are a bit stubborn.”


Read More..

EU privacy regulators take aim at Google privacy policy


BRUSSELS (Reuters) - European data watchdogs said on Monday they plan to take action against Google by this summer for its privacy policy, which allows the search engine to pool user data from across all its services ranging from YouTube to Gmail.


The move is the latest in a skirmish between the web giant and Europe's data protection regulators who view the privacy rules put in place in March by Google as "high risk," although have stopped short of declaring them illegal.


Regulators view the bundling of data on users as potentially constituting a high risk to individuals' privacy.


Google last year consolidated 60 privacy policies into one, combining data collected on individual users across its services, including YouTube, Gmail and social network Google+. Users cannot opt out.


In October, Europe's 27 data regulators gave Google four months to change its approach, listing 12 "practical recommendations" for it to bring its privacy policy into line.


On Monday the French privacy regulator, which last year led an initial inquiry into the tech giant's new policy, said it would set up a further inquiry because Google had not yet addressed their concerns.


"Google did not provide any precise and effective answers," the French regulator CNIL said.


"In this context, the EU data protection authorities are committed to act and continue their investigations. Therefore, they propose to set up a working group, led by the CNIL, in order to coordinate their reaction, which should take place before summer."


Google said it did respond to CNIL on January 8 by listing steps already taken to address their concerns.


"We have engaged fully with CNIL throughout the process and will continue to do so," Al Verney, a spokesperson said.


He added that the privacy policy did respect European law.


The pooling of anonymous user data across Google services, is a big advantage when selling online ads.


Google and other large internet groups such as Facebook provide free services to consumers and earn money from selling ads that they say are more closely targeted than traditional TV or radio campaigns.


(Reporting by Claire Davenport; editing by Leila Abboud and Keiron Henderson)



Read More..

Singer Mindy McCready dies in apparent suicide


HEBER SPRINGS, Ark. (AP) — Perhaps there was one heartbreak too many for Mindy McCready.


The former country star apparently took her own life on Sunday at her home in Heber Springs, Ark. Authorities say McCready died of a suspected self-inflicted gunshot to the head and an autopsy is planned. She was 37, and left behind two young sons.


McCready had attempted suicide at least three times since 2005 as she struggled to cope amid a series of tumultuous public events that marked much of her adult life.


Speaking to The Associated Press in 2010, McCready smiled wryly while talking about the string of issues she'd dealt with over the last half-decade.


"It is a giant whirlwind of chaos all the time," she said of her life. "I call my life a beautiful mess and organized chaos. It's just always been like that. My entire life things have been attracted to me and vice versa that turn into chaotic nightmares or I create the chaos myself. I think that's really the life of a celebrity, of a big, huge, giant personality."


This time it seems the whirlwind overwhelmed McCready.


Her death comes a month after that of David Wilson, her longtime boyfriend and the father of her youngest son. He is believed to have shot himself on the same porch of the home they shared in Heber Springs, a small vacation community about 65 miles north of Little Rock. His death also was investigated as a suicide.


It was the most difficult moment in a life full of them. McCready issued a statement last month lamenting his death. And she called him her soul mate and a caregiver to her sons in an interview with NBC's "Today" show.


"I just keep telling myself that the more suffering that I go through, the greater character I'll have," she said, according to a transcript of the interview.


Like so many times before, McCready showed a little toughness in the midst of a personal storm, again endearing herself to her fans. But as usual, the brave face for the camera hid a much more complicated internal struggle that surfaced publicly time and again over the last 10 years.


This time, along with her remembrances of finding Wilson as he lay dying, she also answered questions about whether they'd argued earlier that evening about an affair and if she'd shot him.


"Oh, my God," the "Today" transcript reads. "No. Oh, my God. No. He was my life. We were each other's life."


It's unclear what circumstances led to McCready taking her own life, but it appears she was struggling again with twin issues that have persisted for years — substance abuse and the custody of her children. She checked into court-ordered rehab and gave her children up to foster care earlier this month after her father asked a judge to intervene, saying she'd stopped taking care of herself and her sons and was abusing alcohol and prescription drugs.


It's unclear why McCready was out of rehab.


A publicist for Billy McKnight, McCready's former boyfriend and the father of her oldest son, said the children remain in foster care. Arkansas Department of Human Services spokeswoman Amy Webb could not confirm their whereabouts, citing agency rules.


McCready's relationship with McKnight was one of the more difficult periods of her life. McKnight was arrested in 2005 on charges of attempted murder after authorities say he beat and choked her. And the two continued to struggle over their son with McKnight recently filing for custody in light of McCready's latest sting in rehab.


McKnight was unavailable for comment Monday morning.


McCready made headlines in April 2008 when she claimed a longtime relationship with baseball great Roger Clemens. Published reports at the time said she met the pitcher at a Florida karaoke bar when she was 15 and he was 28 and married. Clemens has denied the relationship.


On Monday, Clemens handed a written statement to reporters at the Houston Astros spring training facility in Kissimmee, Fla., where he is serving as a special instructor for the team.


"Yes, that is sad news. I had heard over time that she was trying to get peace and direction in her life. The few times that I had met her and her manager/agent they were extremely nice."


McCready also was engaged to actor Dean Cain in 1997, but their relationship fell apart as well.


Her troubles weren't just romantic. Over time she was arrested for fraudulently obtaining prescription drugs, probation violation, misdemeanor assault of her mother Gayle Inge and other problems.


In 2010, after a stint on Dr. Drew Pinsky's "Celebrity Rehab 3" where she was treated for "love addiction," she told The Associated Press she may have finally found love and the strength to get her life back on track.


Pinsky, whose publicist did not immediately respond to messages asking for comment, called McCready an "angel" in the season finale and expressed hope she would continue to seek treatment in a later interview. McCready suffered a seizure in one of the show's scarier moments. Tests showed she had suffered brain damage, something she attributed to her abuse at the hands of McKnight.


McCready is the fifth celebrity to pass away since appearing on Pinsky's show and the third from Season 3. Alice in Chains bassist Mike Starr and "Real World" participant Joey Kovar both died of overdoses.


She entered her relationship with Wilson, a producer and musician who was 34 when he died last month, a short time later. She'd just met Wilson and talked openly about their relationship in the 2010 interview. Wilson declined to speak on the record.


With a publicist, reporters, cameras, makeup artists and musicians swirling around her during a press day for her last album, "I'm Still Here," McCready fended off questions about a sex tape and said she and Wilson started out as friends.


"And I've never had a relationship like that before where we started completely as friends," she said. "It turned into friends really caring about each other and then it turned into love and I've never had that happen before."


Things didn't remain calm for long, though. Unhappy with custody arrangements, McCready took her older son from her mother, the boy's legal guardian, in late 2011. She fled to Arkansas without permission over what she called child abuse fears. Authorities eventually found McCready hiding in a home without permission and took the boy into custody.


She and Wilson had their son in April 2012.


___


Music Writer Chris Talbott reported from Nashville, Tenn. Sports Writer Noah Trister, in Kissimmee, Fla., contributed to this report.


Read More..

Well: Twins Don't Need C-Sections

Obstetricians increasingly recommend planned Caesarean sections for women having twins, but a new study has found that a C-section for healthy twins usually provides no advantage over vaginal delivery.

Researchers randomly assigned 2,800 mothers carrying healthy twins to either a planned C-section or a planned vaginal delivery. There was no difference in outcome between the two groups. There were serious medical problems, like bone fracture or abnormal levels of consciousness, in 36 babies delivered by C-section and 35 delivered vaginally. Twenty-one babies delivered by C-section died, as did 17 delivered vaginally.

Mothers fared equally well in each group, with serious health problems in 7.3 percent of the C-section mothers and in 8.5 percent of the vaginal delivery group.

The trial was carried out in well-equipped health care settings and by practitioners experienced in multiple births. “These skills should be available to anyone trained in obstetrics,” said the lead author, Dr. Jon Barrett, chief of maternal-fetal medicine at Sunnybrook Health Sciences Center in Toronto. “This indicates the need for the current generation of obstetricians who have these skills to impart them to their students and give women the opportunity for the best choice.”

Results of the study were presented at a medical conference in San Francisco last week.

Read More..

Crowds at St. Peter’s Cry ‘Viva il Papa’ to Benedict





VATICAN CITY — Pope Benedict XVI on Sunday asked the tens of thousands of people who had flocked to St. Peter’s Square to see one of his last public appearances to pray for him and his successor.







Riccardo De Luca/Associated Press

An emotional crowd of well-wishers greeted Pope Benedict XVI as he gave his weekly blessing in St. Peter's Square on Sunday.







Franco Origlia/Getty Images

The pope delivered a blessing from the window of his private apartment.






Speaking from his window in the Apostolic Palace, the pope did not make any direct references to his startling decision to resign, effective Feb. 28. But in his greetings to pilgrims in various languages, he called on them in Spanish to “continue praying for me and for the next pope.”


Thousands — some 50,000 according to Italian news media — filled the square this mild, hazy Sunday morning. They cheered for the pope, calling out “Viva il Papa!” — long live the Pope — and clapping out his name rhythmically: “Be-Ne-De-To!”


Dozens of homemade banners — mostly sheets stapled to wooden planks — swayed throughout the square, each an expression of affection for a pope who stunned the world earlier this week with his unexpected decision to retire, which will make him the first pope to do so in 600 years. “With the pope forever” and “We love you very much,” some banners read.


One seminarian at the front of the crowd held up a simple board that said: “We’ll miss you.”


“He’s meant a lot to me and to other Roman Catholics, it’s important to pay our respects to him before we begin to speak too much about the next pope,” said Mark Baumgarten, a seminarian from Perth Australia, studying in Rome.


In his address, which centered on the beginning of the season of Lent, for Christians a 40-day period of reflection before Easter, the pope called on the church and its members to refocus on God, “repudiating pride and egotism.”


“In the decisive moments of life — indeed, if we look closely, in every moment — we are at a crossroads. Do we want to follow the self, or God? Individual interest or the real good?” he said.


“I was moved, he touched my heart,” said Francesca Della Penna, a Roman who had come to hear the pope with her parish, wanting to be close after his decision to retire, which she called “a courageous decision dictated by prayer, a true message of faith.”


On Sunday evening, the pope retired for a weeklong Lenten spiritual retreat with the members of his household and cardinals and bishop.


Cardinal Gianfranco Ravasi, the president of the Pontifical Council for Culture, is scheduled to preach during the retreat. The pope will not have any public engagements until next Saturday, when he will meet with the President of Italy.


In the meantime, cardinals will gather in Rome in preparation for the conclave to elect his successor. Church law states that a conclave must start between 15 and 20 days after the papacy becomes vacant. But on Saturday, the Vatican spokesman, the Reverend Federico Lombardi said that discussions were ongoing at the Vatican to determine whether the resignation left room to interpret the rules to see if the conclave could begin earlier.


Though support for the pope was widely expressed in St. Peter’s Square, not everyone was happy with his decision.


“We want the pope to remain with us. We think he’s good for the church today, which needs to defend values like life and the family and fight relativism,” said GiovanBattista Varricchio, a political science student at the University of Rome and a member of the Catholic movement “Militia Christi.” “We came because we hope that we can convince him to change his mind.”


Read More..

Intel Israel more than doubles exports, mulls new investment


TEL AVIV (Reuters) - Intel's Israeli subsidiary more than doubled its exports in 2012 to $4.6 billion and is seeking to bring manufacturing of the company's next generation of chips to Israel.


Intel's exports, which rose 109 percent from $2.2 billion in 2011, were boosted by the start of production of chips using 22 nanometer technology at its Kiryat Gat plant in southern Israel, which is now operating at full capacity.


Intel, the world's No. 1 chipmaker, will build chips over the next two to three years with features measuring just 14 nm in Ireland and the United States but the company is already thinking about where it will produce 10 nm chips. The narrower the features, the more transistors can fit on a single chip, improving performance.


Intel Israel executives said they would like to see 10 nm production in Israel.


"The average life of a technology is two to six years so we need to be busy to get the next technology, 10 nanometer," Maxine Fassberg, general manager of Intel Israel, told a news conference on Sunday. "We need to get a decision far enough in advance to be able to upgrade the plant. So for 10 nanometer, decisions will need to be made this year."


Fassberg said upgrading the existing Fab 28 plant in Israel would require a lower investment than building a new plant but would still involve several billion dollars.


Intel Israel has in the past received government grants to help with the costs of its investments and Fassberg told Reuters the company was "constantly in talks with the government".


Intel has invested $10.5 billion in Israel in the past decade, including $1.1 billion in 2012, and has received $1.3 billion in government grants.


The company accounted for 20 percent of Israel's high-tech exports last year and 10 percent of its industrial exports, excluding diamonds.


"If Intel had not increased its exports, Israel's high-tech exports would have shrunk by 10 percent," Intel Israel President Mooly Eden said.


Most of Intel Israel's exports - $3.5 billion - came from its chip manufacturing activities.


Intel is Israel's largest private employer, with 8,542 workers, up 10 percent from 2011. The company has two plants - in Jerusalem and Kiryat Gat - as well as four research and development centers.


Eden said Intel was also committed to investing in start-ups, having invested in 64 Israeli companies since 1996. In July its global investment arm Intel Capital said it would expand its operations in Israel.


(Reporting by Tova Cohen; Editing by Helen Massy-Beresford)



Read More..

Willis' new 'Die Hard' scores with $25M debut


LOS ANGELES (AP) — Bruce Willis remains a die-hard at the box office.


Willis' action sequel "A Good Day to Die Hard" debuted as the weekend's top draw with a $25 million debut from Friday to Sunday. The 20th Century Fox release raised its domestic total to $33.2 million since opening Thursday for Valentine's Day to get a jump on the long President's Day weekend.


The movie comes 25 years after the original "Die Hard" and six years after "Live Free or Die Hard," the hit that resurrected the franchise centered on Willis' relentless New York City cop John McClane.


The previous weekend's No. 1 movie, Universal's comedy "Identity Thief" starring Jason Bateman and Melissa McCarthy, was a close second with $23.4 million to lift its haul to $70.7 million.


Debuting at No. 3 with $21.4 million was Relativity Media's romance "Safe Haven," starring Julianne Hough and Josh Duhamel in an adaptation of the Nicholas Sparks novel about a woman who flees her abusive husband and takes up with a sensitive widower. Since opening on Valentine's Day, "Safe Haven" has taken in $30.3 million.


The Weinstein Co. animated tale "Escape from Planet Earth" opened at No. 4 with $16.1 million. With a voice cast that includes Brendan Fraser, Jessica Alba, Sarah Jessica Parker and Rob Corddry, the movie follows the adventures of aliens captured by the U.S. military.


Making a weak debut at No. 6 was the Warner Bros. teen fantasy "Beautiful Creatures," which pulled in $7.5 million for the weekend and $10 million since opening Thursday. The movie is based on the first in the best-selling series about a Southern misfit (Alden Ehrenreich) who falls under the spell of a teen witch (Alice Englert).


"A Good Day to Die Hard" did solid business despite bad reviews for the latest installment, which sends Willis' McClane to Moscow in search of his estranged son, an undercover spy who winds up teaming with the old man against Russian bad guys.


The movie's success follows notable flops from two other holdovers of the 1980s action scene, Sylvester Stallone with "Bullet to the Head" and Arnold Schwarzenegger with "The Last Stand."


"There's still life left in the 'Die Hard' franchise. Given the fact that pretty much every other R-rated action movie that's come out this year has completely fallen flat, this is a pretty good showing," said Paul Dergarabedian, an analyst for box-office tracker Hollywood.com. Willis in "one of the old-guard action stars who still has a solid career going, whereas a lot of these aging action heroes, unless they're in an ensemble cast, they're not able to draw audiences the way they used to."


Overall Hollywood business remained slow, with revenues off for the fourth-straight weekend compared to the same period last year. Domestic business from Friday to Sunday totaled $141 million, down 9.4 percent from the same weekend a year ago, when "Safe House" and "The Vow" led the way with about $23 million each.


A bright spot this year has been strong business for top Academy Awards contenders leading up to next Sunday's Oscars. The weekend's top-20 films included eight of the nine best-picture nominees, seven of which have either topped $100 million domestically or are close.


Estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Hollywood.com. Where available, latest international numbers are included. Final domestic figures will be released Tuesday.


1. "A Good Day to Die Hard," $25 million.


2. "Identity Thief," $23.4 million.


3. "Safe Haven," $21.4 million.


4. "Escape from Planet Earth," $16.1 million.


5. "Warm Bodies," $9 million.


6. "Beautiful Creatures," $7.5 million.


7. "Side Effects," $6.3 million.


8. "Silver Linings Playbook," $6.1 million.


9. "Hansel and Gretel: Witch Hunters," $3.5 million.


10. "Zero Dark Thirty," $3.1 million.


___


Online:


http://www.hollywood.com


http://www.rentrak.com


___


Universal and Focus are owned by NBC Universal, a unit of Comcast Corp.; Sony, Columbia, Sony Screen Gems and Sony Pictures Classics are units of Sony Corp.; Paramount is owned by Viacom Inc.; Disney, Pixar and Marvel are owned by The Walt Disney Co.; Miramax is owned by Filmyard Holdings LLC; 20th Century Fox and Fox Searchlight are owned by News Corp.; Warner Bros. and New Line are units of Time Warner Inc.; MGM is owned by a group of former creditors including Highland Capital, Anchorage Advisors and Carl Icahn; Lionsgate is owned by Lions Gate Entertainment Corp.; IFC is owned by AMC Networks Inc.; Rogue is owned by Relativity Media LLC.


Read More..

Cuomo Bucks Tide With Bill to Lift Abortion Limits





ALBANY — Bucking a trend in which states have been seeking to restrict abortion, Gov. Andrew M. Cuomo is putting the finishing touches on legislation that would guarantee women in New York the right to late-term abortions when their health is in danger or the fetus is not viable.




Mr. Cuomo, seeking to deliver on a promise he made in his recent State of the State address, would rewrite a law that currently allows abortions after 24 weeks of pregnancy only if the pregnant woman’s life is at risk. The law is not enforced, because it is superseded by federal court rulings that allow late-term abortions to protect a woman’s health, even if her life is not in jeopardy. But abortion rights advocates say the existence of the more restrictive state law has a chilling effect on some doctors and prompts some women to leave the state for late-term abortions.


Mr. Cuomo’s proposal, which has not yet been made public, would also clarify that licensed health care practitioners, and not only physicians, can perform abortions. It would remove abortion from the state’s penal law and regulate it through the state’s public health law.


Abortion rights advocates have welcomed Mr. Cuomo’s plan, which he outlined in general terms as part of a broader package of women’s rights initiatives in his State of the State address in January. But the Roman Catholic Church and anti-abortion groups are dismayed; opponents have labeled the legislation the Abortion Expansion Act.


The prospects for Mr. Cuomo’s effort are uncertain. The State Assembly is controlled by Democrats who support abortion rights; the Senate is more difficult to predict because this year it is controlled by a coalition of Republicans who have tended to oppose new abortion rights laws and breakaway Democrats who support abortion rights.


New York legalized abortion in 1970, three years before it was legalized nationally by the Supreme Court in Roe v. Wade. Mr. Cuomo’s proposal would update the state law so that it could stand alone if the broader federal standard set by Roe were to be undone.


“Why are we doing this? The Supreme Court could change,” said a senior Cuomo administration official, who spoke on the condition of anonymity because the governor had not formally introduced his proposal.


But opponents of abortion rights, already upset at the high rate of abortions in New York State, worry that rewriting the abortion law would encourage an even greater number of abortions. For example, they suggest that the provision to allow abortions late in a woman’s pregnancy for health reasons could be used as a loophole to allow unchecked late-term abortions.


“I am hard pressed to think of a piece of legislation that is less needed or more harmful than this one,” the archbishop of New York, Cardinal Timothy M. Dolan, wrote in a letter to Mr. Cuomo last month. Referring to Albany lawmakers in a subsequent column, he added, “It’s as though, in their minds, our state motto, ‘Excelsior’ (‘Ever Upward’), applies to the abortion rate.”


National abortion rights groups have sought for years to persuade state legislatures to adopt laws guaranteeing abortion rights as a backup to Roe. But they have had limited success: Only seven states have such measures in place, including California, Connecticut and Maryland; the most recent state to adopt such a law is Hawaii, which did so in 2006.


“Pretty much all of the energy, all of the momentum, has been to restrict abortion, which makes what could potentially happen in New York so interesting,” said Elizabeth Nash, state issues manager at the Guttmacher Institute, a research group that supports abortion rights. “There’s no other state that’s even contemplating this right now.”


In most statehouses, the push by lawmakers has been in the opposite direction. The past two years has seen more provisions adopted at the state level to restrict abortion rights than in any two-year period in decades, according to the Guttmacher Institute; last year, 19 states adopted 43 new provisions restricting abortion access, while not a single significant measure was adopted to expand access to abortion or to comprehensive sex education.


“It’s an extraordinary moment in terms of the degree to which there is government interference in a woman’s ability to make these basic health care decisions,” said Andrea Miller, the president of NARAL Pro-Choice New York. “For New York to be able to send a signal, a hopeful sign, a sense of the turning of the tide, we think is really important.”


Abortion rights advocates say that even though the Roe decision supersedes state law, some doctors are hesitant to perform late-term abortions when a woman’s health is at risk because the criminal statutes remain on the books.


“Doctors and hospitals shouldn’t be reading criminal laws to determine what types of health services they can offer and provide to their patients,” said M. Tracey Brooks, the president of Family Planning Advocates of New York State.


For Mr. Cuomo, the debate over passing a new abortion law presents an opportunity to appeal to women as well as to liberals, who have sought action in Albany without success since Eliot Spitzer made a similar proposal when he was governor. But it also poses a challenge to the coalition of Republicans and a few Democrats that controls the State Senate, the chamber that has in the past stood as the primary obstacle to passing abortion legislation in the capital.


The governor has said that his Reproductive Health Act would be one plank of a 10-part Women’s Equality Act that also would include equal pay and anti-discrimination provisions. Conservative groups, still stinging from the willingness of Republican lawmakers to go along with Mr. Cuomo’s push to legalize same-sex marriage in 2011, are mobilizing against the proposal. Seven thousand New Yorkers who oppose the measure have sent messages to Mr. Cuomo and legislators via the Web site of the New York State Catholic Conference.


A number of anti-abortion groups have also formed a coalition called New Yorkers for Life, which is seeking to rally opposition to the governor’s proposal using social media.


“If you ask anyone on the street, ‘Is there enough abortion in New York?’ no one in their right mind would say we need more abortion,” said the Rev. Jason J. McGuire, the executive director of New Yorkers for Constitutional Freedoms, which is part of the coalition.


Members of both parties say that the issue of reproductive rights was a significant one in November’s legislative elections. Democrats, who were bolstered by an independent expenditure campaign by NARAL, credit their victories in several key Senate races in part to their pledge to fight for legislation similar to what Mr. Cuomo is planning to propose.


Republicans, who make up most of the coalition that controls the Senate, have generally opposed new abortion rights measures. Speaking with reporters recently, the leader of the Republicans, Dean G. Skelos of Long Island, strenuously objected to rewriting the state’s abortion laws, especially in a manner similar to what the governor is seeking.


“You could have an abortion up until the day the child would be born, and I think that’s just wrong,” Mr. Skelos said. He suggested that the entire debate was unnecessary, noting that abortion is legal in New York State and saying that is “not going to be changed.”


The Senate Democratic leader, Andrea Stewart-Cousins of Yonkers, who is the sponsor of a bill that is similar to the legislation the governor is drafting, said she was optimistic that an abortion measure would reach the Senate floor this year.


“New York State’s abortion laws were passed in 1970 in a bipartisan fashion,” she said. “It would be a sad commentary that over 40 years later we could not manage to do the same thing.”


Read More..

A First Step on Continent for Google on Use of Content


PARIS — Publishers in France say they have struck an innovative agreement with Google on the use of their content online. Their counterparts elsewhere in Europe, however, say the French gave in too easily to the Internet giant.


The deal was signed this month by President François Hollande of France and Eric E. Schmidt, the executive chairman of Google, who called it a breakthrough in the tense relationship between publishers and Google, and as a possible model for other countries to follow.


Under the deal, Google agreed to set up a fund, worth €60 million, or $80 million, over three years, to help publishers develop their digital units. The two sides also pledged to deepen business ties, using Google’s online tools, in an effort to generate more online revenue for the publishers, who have struggled to counteract dwindling print revenue.


But the French group, representing newspaper and magazine publishers with an online presence, as well as a variety of other news-oriented Web sites, yielded on its most important demand: that Google and other search engines and “aggregators” of news should start paying for links to their content.


Google, which insists that its links provide a service to publishers by directing traffic to their sites, had fiercely resisted any change in the principle of free linking.


The agreement dismayed members of the European Publishers Council, a lobbying group in Brussels, which has been pushing for a fundamental change in the relationship between publishers and Google. The group criticized the French publishers for breaking ranks and striking a separate business agreement that has no statutory standing.


The deal “does not address the continuing problem of unauthorized reuse and monetization of content, and so does not provide the online press with the financial certainty or mechanisms for legal redress which it needs to build sustainable business models and ensure its continued investment in high-quality content,” Angela Mills Wade, executive director of the publishers council, said in a statement.


German publishers were also scornful, with Anja Pasquay, a spokeswoman for the German Newspaper Publishers’ Association, saying: “Obviously the French position isn’t one that we would favor. This is not the solution for Germany.”


Germany has been in the forefront of the push to get Google to share with online news publishers some of the billions of euros that the company earns from the sale of advertising. A proposed law, endorsed by the government of Chancellor Angela Merkel and working its way through the federal legislature, would grant a new form of copyright to digital publishers. If enacted, it could allow publishers to charge search engines or aggregators for displaying even snippets of news articles alongside links to other Web sites.


Mr. Hollande had vowed to introduce similar legislation this winter if Google and the publishers did not come to terms. It appears that Google, which had threatened to stop indexing French Web sites’ content if it had to pay for links, has sidelined the threat of legislation, at least for now; the agreement will be reviewed after three years, Mr. Hollande has said.


Under the deal, Google says it will help the publishers use several of its digital advertising services, including AdSense, AdMob and Ad Exchange, more effectively.


Publishers are already free to use these services, and it was not immediately clear how they would be able to generate more revenue from them; this part of the accord remains confidential, both sides say, because they are still negotiating the fine print.


“This agreement can help accelerate the move toward greater advertising revenues in the digital world,” said Marc Schwartz of Mazars, a consulting firm, who is serving as an independent mediator in the talks. “I’m not saying we have done everything, but it’s a first step in the right direction.”


More has been said about the planned innovation fund. Publishers will submit proposals to the fund, which will select ideas to finance and develop, with the involvement of Google engineers.


“The idea is that it would inject innovation into the sector in France,” said Simon Morrison, copyright policy manager at Google.


Read More..